STOCK TITAN

Stock Market News for January 13, 2026

666 news published.

Big Banks & Strategic Deals

JPMorgan Chase (JPM)'s quarterly print remains the anchor for financial‑sector positioning, while U.S. Bancorp (USB)'s agreement to acquire BTIG refocuses attention on wholesale capabilities and regional fee pools.

The Bancorp (TBBK)'s rebrand signals a push into fintech partnerships that could reshape revenue mix amid evolving M&A dynamics.

Fifth Third (Fifth Third Bancorp) and Comerica (CMA) announced they have received all material regulatory approvals to combine. The merger would reshape regional banking footprints and create a national scale player, with implications for deposit mixes and branch rationalization.

Tech, AI & Infrastructure

DigitalOcean (DOCN)'s Inference Cloud powered by AMD Instinct GPUs showing 2x inference gains is a practical differentiator for mid‑market AI workloads.

DocuSign (DOCU) rolled out an AI that translates legalese and automates contracts, a feature that could broaden adoption among procurement and legal teams and force competitors to sharpen workflow AI hooks.

CrowdStrike (CRWD) agreed to acquire Seraphic, extending endpoint coverage into browser‑level protection and expanding its zero‑trust addressable market.

Teradyne (TER) set a date to report Q4 and FY2025 results, a key read on test-equipment demand tied to semiconductor capital spending and factory automation cycles.

Match Group (MTCH) set a calendar item to announce Q4 and FY2025 results, an event investors watch for subscriber trends and monetization shifts in ad and subscription models across dating apps.

Semiconductors & Materials

Wolfspeed (WOLF)'s 300mm SiC progress remains central to EV and power‑electronics cost curves, while Solstice Advanced Materials (SOLS)'s >$220M expansion underscores supply scaling for defense and protective markets.

Illumina (ILMN) provided preliminary Q4 and FY2025 results and unveiled a Billion Cell Atlas, tying sequencing demand to computational biology tailwinds investors will prize.

Impinj (PI) reported preliminary Q4 revenue and adjusted EBITDA, a useful read on RFID adoption and inventory‑tracking spend across retail and logistics suppliers.

Defense, Aerospace & Manufacturing

Kratos (KTOS) opened a 55,000‑sq.‑ft. hypersonic facility, reinforcing capacity for DoD programs and signaling follow‑on production expectations.

Teledyne (TDY) announced Q4 and full‑year 2025 webcast details, a date market participants watch for aerospace instrumentation trends and backlog updates.

Velo3D (VELO) and Intuitive Machines (LUNR)'s recent partnership and acquisition activity continue to highlight additive manufacturing and small‑sat capabilities as procurement moves from pilots to production.

Energy, Utilities & Renewables

EVgo (EVGO) keeps expanding retail fast charging, while ENGIE and Ares (ARES)'s 730 MW addition highlights continued utility‑scale renewables growth.

ExxonMobil (XOM) set timing to release fourth‑quarter 2025 results, a report that often shifts energy sector valuations because of refining margins, production guidance and cash‑return programs.

EOG Resources (EOG) scheduled its Q4 and full‑year 2025 webcast for Feb. 25, a key date for shale production trends and reserve guidance that can move oil‑service names.

Patterson‑UTI Energy (PTEN) announced a Q4 earnings conference call, another data point for utilization and rig‑activity trends that ripple through oil‑service equities.

Newmont (NEM) announced its Q4 and FY2025 results conference call, a timely data point for gold prices, cost curves and capital‑allocation policy in the miners group.

Healthcare, Biotech & Clinical Developments

Humana (HUM) expanded cancer care for Medicare Advantage members via an Atlas Oncology partnership, potentially shifting utilization and oncology economics in managed care.

Aptar (ATR)'s nasal vaccine delivery solutions are featured in a Phase II intranasal COVID‑19 vaccine trial, an example of med‑tech firms capturing durable product demand from biologics developers.

TG Therapeutics (TGTX) provided preliminary Q4 and FY2025 net product revenue and 2026 guidance, plus anticipated development milestones—critical signals for investors in small‑cap oncology and immunology franchises.

Rapid Micro Biosystems (RPID) announced record preliminary Q4 and FY2025 revenue, evidence of durable lab‑automation demand that supports margin leverage in life‑science tools.

Travere Therapeutics (TVTX) said the FDA extended review of the sNDA for FILSPARI® (sparsentan) in FSGS—an outcome that can materially affect near‑term revenue potential for a rare‑disease program.

Capital Markets, Financing & Credit Moves

Jefferies Financial Group (JEF) priced $1.5 billion of 5.50% senior notes due 2036, a sizable debt placement that helps fund balance‑sheet strategies and influences funding spreads across regional and investment‑bank peers.

Rithm Capital Corp. (RITM) announced pricing of a public offering of preferred stock, a capital move that adjusts yield profiles for asset managers and affects tangible book dynamics.

Burford Capital (BUR) announced pricing and an upsizing of a private offering of senior notes, a liquidity event that investors will parse for capital structure and litigation‑finance yield dynamics.

Belden (BDC) priced a €450 million private offering of 4.250% senior subordinated notes, a sizable debt placement that affects leverage metrics and refinancing runway for industrial networking investments.

Government Contracts & Services

ICF (ICFI) secured $300 million in new European contracts, a material boost to backlog that should support revenue visibility and margin leverage across consulting and engineering services.

Kratos (KTOS)'s manufacturing expansion and Velo3D (VELO)'s Army partnerships continue a theme of defense procurement moving toward domestic scale‑up.

Selected Corporate & Market Access Moves

Market focus remains on earnings cadence, AI product momentum, strategic asset deals and capital‑markets moves that can shift valuations and positioning. Watch the upcoming earnings webcasts—particularly from energy and materials names—and the biotech revenue and guidance updates for the next wave of analyst revisions.

12 jan 2026 14 jan 2026
IMPACT
SENTIMENT
01/13/2026 06:20 PM
low float penny stock
IMPACT
SENTIMENT
01/13/2026 06:20 PM
private placement low float penny stock
IMPACT
SENTIMENT
01/13/2026 05:30 PM
private placement low float penny stock
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
01/13/2026 04:27 PM
dividends low float
IMPACT
SENTIMENT
IMPACT
SENTIMENT
01/13/2026 04:15 PM
dividends low float
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
01/13/2026 09:00 AM
low float penny stock
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
01/13/2026 08:30 AM
private placement penny stock
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
01/13/2026 08:00 AM
low float penny stock
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
01/13/2026 07:20 AM
management low float penny stock
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
01/13/2026 06:39 AM
dividends
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
IMPACT
SENTIMENT
12 jan 2026 14 jan 2026

Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.

Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.

What You'll Find on This Page: